Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.

This study tests a new drug called SKB518, given alone or with standard chemotherapy, in 290 people with advanced ovarian, cervical, or endometrial cancer. The goal is to see if it can shrink tumors or slow cancer growth. Participants must be 18–75 years old and in good enough he…